# Preventieve cardiologie bij kinderen: vroegtijdige interventie tegen hart- en vaatziekten

*geplaatst 2026-09-14 · Hypertensie · Current opinion in pediatrics · doi 10.1097/MOP.0000000000001614 · https://hartvaat.nl/2026/10/01/preventieve-cardiologie-bij-kinderen-vroegtijdige-interventie-tegen-hart-en-vaat/*

Deze overzichtsstudie belicht de preventie en behandeling van cardiovasculaire risicofactoren zoals hypertensie, dyslipidemie en obesitas bij kinderen en adolescenten. De auteurs benadrukken dat het optimaliseren van leefstijlfactoren en metabole parameters volgens de AHA-richtlijnen cruciaal is om latente hart- en vaatziekten te voorkomen. Hoewel leefstijladvies nog steeds de basis vormt, komen er nieuwe farmaceutische opties beschikbaar voor de behandeling van obesitas en dyslipidemie in deze leeftijdsgroep. Voor huisartsen en internisten is tijdige signalering en begeleiding van jonge patiënten essentieel voor langetermijngezondheid.

## English: The role of preventive cardiology in children.

This narrative review outlines the prevention and management of cardiovascular risk factors, including hypertension, dyslipidemia, and obesity, in children and adolescents. Emphasizing the American Heart Association’s Life’s Essential 8 framework, the authors highlight that early optimization of lifestyle and metabolic parameters is critical to preventing adult-onset cardiovascular disease. While lifestyle modification remains foundational, emerging pharmacotherapies for pediatric obesity and dyslipidemia offer new clinical options. Primary care physicians and internists should prioritize early risk assessment and sustained counseling to improve long-term cardiometabolic outcomes.

## Abstract (original, from the publication)

PURPOSE OF REVIEW: This review examines prevalence, diagnosis, and management strategies for cardiovascular risk factors including dyslipidemia, hypertension, and obesity in children and adolescents. As these risk factors begin in childhood and track into adulthood, early intervention is important in preventing cardiovascular disease, the leading cause of mortality in the United States. RECENT FINDINGS: The American Heart Association's Life's Essential 8 characterizes components of cardiovascular health including health behaviors (diet, exercise, sleep, tobacco use) and health factors (blood lipids, blood pressure, blood glucose, and weight). Optimizing these health metrics is associated with favorable overall and cardiovascular health (CVH) outcomes. In the United States, prevalence of hypertension, obesity, and cardiovascular disease is projected to rise over the next decade, while hypercholesterolemia is declining. While lifestyle modifications remain a cornerstone in care, new pharmacotherapeutic options have emerged for children over the past several years to treat dyslipidemia and obesity. SUMMARY: Pediatric clinicians have an important role in counseling and supporting CVH in children. This review examines aspects of CVH that are commonly managed in preventive cardiology programs, focusing on diagnostic evaluation and treatment strategies, highlighting new and emerging therapies for children and adolescents, including pharmacotherapy and latest research on effective lifestyle modifications.

Auteurs: Michelle Ghandhi Degen, Shannon M Lyon

---
Bron: Current opinion in pediatrics, https://doi.org/10.1097/MOP.0000000000001614. Bijgewerkt 2026-09-08T01:01:45Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.